Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Rangering i aksjer #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Aksjekurs
$0.106
Sist synkronisert: 2026-10-01
Markedsverdi
$767.67K
Endring (1 dag)
73.77%
Endring (1 år)
-84.81%
Land
US
Handel Mosaic ImmunoEngineering Inc. (CPMV)

Kategori

P/B-forhold for Mosaic ImmunoEngineering Inc. (CPMV)
P/B-forhold per 2026 TTM: 0
Ifølge Mosaic ImmunoEngineering Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Mosaic ImmunoEngineering Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.5558 -
US
11.2791 -
US
4.0142 -
AU
7.082 -
NL
- -
CH